KLRF1
Killer cell lectin-like receptor subfamily F member 1
Also known as: CLEC5C, KLRF1_HUMAN, NKp80
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZS2
- Gene
- KLRF1
- Ensembl
- ENSG00000150045
- Chromosome
- 12
- Canonical length
- 231 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Plasma membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
KLRF1, an activating homodimeric C-type lectin-like receptor (CTLR), is expressed on nearly all natural killer (NK) cells and stimulates their cytoxicity and cytokine release (Kuttruff et al., 2009 [PubMed 18922855]).[supplied by OMIM, Oct 2009]
Canonical amino-acid sequenceUniProt
231 residues, UniProt reviewed canonical sequence.
>Q9NZS2|KLRF1
1 MQDEERYMTL NVQSKKRSSA QTSQLTFKDY SVTLHWYKIL LGISGTVNGI LTLTLISLIL
61 LVSQGVLLKC QKGSCSNATQ YEDTGDLKVN NGTRRNISNK DLCASRSADQ TVLCQSEWLK
121 YQGKCYWFSN EMKSWSDSYV YCLERKSHLL IIHDQLEMAF IQKNLRQLNY VWIGLNFTSL
181 KMTWTWVDGS PIDSKIFFIK GPAKENSCAA IKESKIFSET CSSVFKWICQ YLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KLRF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- spleen: 17 nTPM
- bone marrow: 12 nTPM
- liver: 4.2 nTPM
- lung: 4.1 nTPM
- epididymis: 3.6 nTPM
- tonsil: 3.3 nTPM
Single-cell type
- nk-cells: 512 nCPM
- t-cells: 33 nCPM
- innate lymphoid cells: 12 nCPM
- sertoli cells: 8.7 nCPM
- cdc: 7.3 nCPM
- cholangiocytes: 7.2 nCPM
Immune cell
- NK-cell: 666 nTPM
- MAIT T-cell: 95 nTPM
- total PBMC: 83 nTPM
- gdT-cell: 72 nTPM
- naive CD8 T-cell: 36 nTPM
- memory CD8 T-cell: 35 nTPM
Brain region
- medulla oblongata: 0.8 nTPM
- cerebral cortex: 0.7 nTPM
- hypothalamus: 0.5 nTPM
- pons: 0.5 nTPM
- thalamus: 0.5 nTPM
- amygdala: 0.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.48
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.46
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KLRF1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KLRF1 as an antibody target. Whether an autoantibody or antibody against KLRF1 could matter depends on whether native KLRF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KLRF1 is annotated at the cell surface, where native KLRF1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KLRF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...